FDA approves first SMA muscle-loss drug; studies link gut, genes to brain aging
· 8 source(s)
Short summary
STAT reports that Scholar Rock won FDA approval for Isembyld, the first drug targeting SMA muscle loss; a late-stage trial found motor skills improved after a year when combined with an SMN2-targeting drug. A study in Pediatrics, reported by Medical Xpress, found burnout indicators among pediatricians decreased from 2021 to 2025. STAT also reports an E.U. advocate general recommended annulling part of a directive requiring drugmakers to finance 80% of wastewater treatment costs. Medical Xpress items describe UCLA findings linking brain aging speed to gut bacteria, Columbia University research
Mind map
Health news digest
Drag to pan · pinch or the + / − buttons to zoom · swipe up or down to scroll the page.
Read the map as an outline
-
Drug approvals and policy
- STAT: FDA approves Isembyld for SMA muscle loss
- STAT: trial shows motor skill gains with SMN2 drug
- STAT: E.U. adviser urges annulling wastewater cost rule
-
Brain aging and Alzheimer's
- UCLA links brain aging speed to gut bacteria
- Columbia predicts Alzheimer's symptoms three to six years ahead
- Blood and gene tests used for prediction
-
Genetics and disease risk
- Complex traits draw heritability from intergenic DNA
- Schizophrenia and cholesterol cited as examples
- Huntsman: obesity blocks process killing cancer cells
-
Clinical practice and workforce
- Pediatrics study: pediatrician burnout indicators fell 2021-2025
- AI tools could individualize postoperative opioid prescribing
Map your own version
This post is a mind map of what today's sources reported. Start with a blank canvas and build the same thing for whatever you are working on — it opens straight away, no account needed until you want to keep it.
Sources
- STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss — STAT
- 2021 to 2025 saw reduction in burnout indicators among pediatricians — Medical Xpress - latest medical and health news stories
- STAT+: Pharma wins a battle over the cost of wastewater treatment in Europe — STAT
- Genetic mapping reveals complex traits draw more heritability from intergenic DNA — Medical Xpress - latest medical and health news stories
- Brain aging may be detected decades before symptoms appear, with links to gut health — Medical Xpress - latest medical and health news stories
- Blood and gene tests predict Alzheimer's symptoms three to six years ahead — Medical Xpress - latest medical and health news stories
- AI tools could make postoperative opioid prescribing more individualized — Medical Xpress - latest medical and health news stories
- New findings link obesity to loss of natural breast cancer protection — Medical Xpress - latest medical and health news stories
Written by an AI model from the sources listed above, then published without edits. It summarises what those sources reported and adds nothing of its own — for the full story, follow the links. Model: deepseek-chat.
More health
- Health Digest: PTSD Genetics, Vitamin D, GLP-1 Risks and More — Sep 17, 2026
- Health digest: reading, Alzheimer's, RSV, air pollution, IL-2, RNA — Sep 15, 2026
- Health digest: aging, cancer, pricing, measles, antibodies — Sep 14, 2026
- Lung cancer trials and health studies reported — Sep 13, 2026